Publications and communications of Eva Lucarelli

Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., Mariavelle, E., O'Grady, T. M., Hassoun, Z. E. O., Claes, M., Dubois, L., Lee, K. A. W., Kruys, V., Gueydan, C., Durand, J., Hervouet, E., Geyer, F. H., Banito, A., Imle, R., ... Dequiedt, F. (16 July 2025). Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nature Communications, 16 (1), 6537. doi:10.1038/s41467-025-61725-x

Lucarelli, E., Ongena, L., Dubois, L., Galvan, B., Bruyr, J., & Dequiedt, F. (17 October 2024). FET fusion oncoproteins rewire alternative splicing patterns to drive sarcomagenesis [Poster presentation]. EMBO/EMBL Symposium: The complex life of RNA, Heidelberg, Germany.